Blog

Unprecedented

Reading Time: 8 Minutes

Published July 11, 2026

Morning Report — Not Your Typical Medical Newsletter

We get it, you see a lot of medical newsletters, so hear us out. Once a month, we’ll highlight important medical news sprinkled with witty commentary, fun facts, giveaways, and more… because learning should be fun! Subscribe to receive the Morning Report directly.

Morning Report: Not Your Typical Newsletter. Sponsored by Corcept Therapeutics

Good morning! For most of two thousand years, the answer to almost any ailment was to remove some blood. Fever, headache, pneumonia, melancholy. Out came the lancet or the leeches, and out went a few ounces of the patient. As the nation marks its 250th anniversary this month, consider the fate of George Washington. Stricken with a throat infection in 1799, he repeatedly submitted to bloodletting. Over the course of a day, his physicians removed an estimated 40% of his blood volume. He was dead by nightfall.

Bloodletting got nearly everything wrong, and medicine spent the next two centuries learning to put blood back rather than drain it. So, there is a small irony in the following report, which hinges on deliberately cutting off the blood supply, very precisely, to a single target, and leaving the patient better for it.

Choking Off Knee Pain at the Source

Joint Effort

Knee osteoarthritis is the sort of problem primary care sees daily and often treats with increasing resignation: NSAIDs, weight loss, physical therapy, the occasional steroid injection, and eventually a referral for a knee replacement that nobody seems particularly excited about. A study published this past month offers a possible option for the long stretch in between.

GAE: The space between

The procedure, genicular artery embolization (GAE), seems counterintuitive. Rather than adding lubrication, reducing inflammation pharmacologically, or replacing the joint, an interventional radiologist deliberately blocks abnormal small arteries supplying the inflamed synovium. Because arthritic knees develop abnormal blood vessels and accompanying nerve growth that may perpetuate pain and inflammation, reducing blood flow may interrupt the cycle.

Investigators ran 239 procedures with rapidly resorbable gelatin microspheres in 194 patients (median age 69) who had failed at least three months of conservative therapy. Median pain scores fell from 7 at baseline to 4 at six weeks and 3 at both six and twelve months. Daily activity scores rose from 53 to 72, and the notoriously unforgiving sports-and-recreation subscale more than doubled, from 15 to 36. By one year, 80% achieved clinically meaningful improvement, with no serious complications, and mild, self-limited reactions in fewer than 7%.

Big, bold asterisk

Before you run with this: there was no control group. Knee osteoarthritis pain carries a large, well-documented placebo response, especially for procedures, so uncontrolled pain studies almost always look impressive. A fifth of patients dropped out by one year. Further, the study ended about nine years short of answering the question we really care about.

Key takeaways

For patients stranded between cortisone shots and a knee replacement, GAE is worth knowing about and worth a conversation with interventional radiology. Present it as promising but unproven: the real size of the benefit won’t be clear until stronger sham-controlled trials are in, and for now it stays investigational and rarely covered. Knee osteoarthritis has a long history of humbling therapies that looked good early.

For more education on osteoarthritis, check out this CME activity: Metformin: A Fresh Angle for Treating Knee Osteoarthritis

A Tale of Two Schedules

Women's Health Watch

In medicine, committees usually argue quietly in conference rooms. This year they decided to publish separate calendars. For the first time, the American College of Obstetricians & Gynecologists (ACOG) has released its own maternal immunization schedule rather than point people to the CDC’s guidelines.

ACOG recommendations

Most of the new schedule will look familiar. ACOG continues to recommend inactivated influenza vaccine and COVID-19 vaccination at any gestational age, Tdap at 27 to 36 weeks, and seasonal maternal RSV vaccination at 32 weeks 0 days through 36 weeks 6 days during the first eligible pregnancy. Subsequent pregnancies do not require repeat RSV vaccination; instead, infants should receive a monoclonal antibody. Pneumococcal, meningococcal, hepatitis A, and hepatitis B vaccines remain risk-based decisions, while HPV, MMR, and varicella are deferred until before or after pregnancy.

Fork in the road

The major split is over COVID-19 vaccination. ACOG continues to recommend vaccination during pregnancy, while federal guidance no longer recommends COVID-19 vaccination for healthy pregnant women. The break was telegraphed earlier this year when ACOG withdrew from the CDC vaccine advisory process after changes directed by Health Secretary Robert F. Kennedy Jr.

Key takeaways

ACOG may have broken from federal guidance, but it is hardly standing alone. Thirteen medical and public health organizations, including the AAFP and AAP, have endorsed the schedule. As the gap between specialty societies and federal agencies continues to widen, clear documentation of counseling, individualized risk assessment, and transparent discussions of the evidence become as important as the vaccine recommendations themselves. Clinicians are now practicing medicine in the small overlap of a Venn diagram that used to be a circle.

For more education on vaccines, check out this CME activity: Meningitis Makes a Comeback (Along with Other Infections) - Frankly Speaking Vaccine Update

The Glass-Half-Full Hypothesis

Healthy Aging

Medicine often treats age 65 the way electronics manufacturers treat the end of a warranty period: after this point, any continued function should be regarded as a pleasant surprise. But a new analysis from Yale suggests that aging has more than one trajectory.

Beyond the warranty

Yale researchers followed more than 11,000 adults aged 65-plus for up to 12 years, measuring global cognition and walking speed—two useful barometers of aging. Nearly 45% improved in one or both. About one-third improved cognitively, more than one-quarter improved walking speed, and many improvements were clinically significant. Even participants who started with normal cognition and mobility often improved. When stable cognition also counted as success, more than half of participants avoided the decline that popular culture—and often medicine—treats as inevitable. The authors note that averages flatten these individual trajectories; mix enough gains and losses and everyone seems to drift gently downward.

Ageism as a risk factor?

Researchers noted that the people who held more positive beliefs about aging at baseline were significantly more likely to improve in both body and mind, an association that survived adjustment for age, sex, education, chronic disease, depression, and length of follow-up.

The catch

This is observational, and belief studies are slippery. Did less healthy (and often less optimistic) participants drop out or die, leaving a cohort enriched for resilience and optimism—thereby exaggerating the link? Repeat cognitive testing also invites practice effects that can pass for real gains. Finally, the authors have long championed the idea that age beliefs are causal, so the framing reflects that perspective.

Key takeaways

The study cannot prove that positive age beliefs strengthen gait or memory, and healthier individuals may simply hold more favorable views of aging. Still, the results offer a useful corrective to the reflexive, “Well, that’s just aging.” Decline is neither uniform nor inevitable, and measurable gains in cognition and mobility are more common than many clinicians assume. Challenging a patient’s fatalism about aging is reasonable, low risk, and may itself have therapeutic value. Bottom line: We may not need to assume that aging always proceeds in one direction: downhill, preferably with a handrail.

For more education on healthy aging, check out this CME activity: Physical Activity for Healthy Aging: How Much Is Enough?

Interested in more healthcare news? Here are some other articles we don’t want you to miss:

Morning Report is written by:

Alissa Scott, Author
Aylin Madore, MD, MEd, Editor
Margaret Oliverio, MD, Editor
Ariel Reinish, MD, MEd, Editor
Emily Ruge, Editor

Did You Enjoy This Issue of Morning Report?

Absolutely! | For the most part | Not at all

Click above, or share your feedback via email. Drop us an email at morningreport@pri-med.com to let us know how we’re doing.

Please note that the summaries in Morning Report are intended to provide clinicians with a brief overview of an article, and while we do our best to select the most salient points, we ask that you please read the full article linked in each summary for clarification before making any practice-changing decisions.

Enjoying Morning Report? Share It with Colleagues!

Is Morning Report for you? It is if you’re someone who needs quick-hitting, accurate medical news—but with some flair.

You don’t just need to know about the latest metabolism study—you also need to know how it parallels an Alanis Morissette hit. If you’re reading about acupuncture treatment, you need us to skip the needle puns and get straight to the point. We keep things simple, but when we do get into the scientific weeds, we always remind you to check for ticks.

Subscribe to receive Morning Report directly in your inbox the first Saturday of every month.